4,6-Dimethylpyrimidin-2-ol hydrochloride, 95.0%, 25g

1-(2,6-Difluorobenzoyl)piperidin-4-one, 95.0%, 1g

1-(3-BROMOPHENYL)-2,2-DIFLUOROETHANONE, 95.0%, 250mg

Éter diisopropílico, mínimo 98%, para síntesis, estab., 10 l, bl.

Anhídrido 2-sulfobenzoico, mínimo 85 %, para bioquímica, 25 g, envase de vidrio

(2-((tert-Butoxycarbonyl)amino)-7-fluorobenzo[d]thiazol-4-yl)boronic acid, 97%, 5g

Bathocuproine>95.0%(T)(HPLC)1g

CABAZITAXEL, 98%, 1g

Ethyl 1-methyl-5-nitroimidazole-2-carboxylate, 98.0%, 250mg

3-BROMO-2-(TRIFLUOROMETHYL)ANILINE, 95.0%, 250mg

(E)-Methyl 4-methoxybut-2-enoate, 98%, 25g

Tetrafluorosuccinic Anhydride>98.0%(GC)(T)5g